Next |
home / stock / enlv / enlv message board
Subject | By | Source | When |
---|---|---|---|
Fundamentals on this one are amazing | WolfKlaw | investorshub | 04/24/2021 4:28:44 AM |
Yeah, I call that all steak and no | Clemdane | investorshub | 04/23/2021 7:05:39 PM |
This company has so much potential upside I | WolfKlaw | investorshub | 04/09/2021 9:20:41 AM |
You as well! | Clemdane | investorshub | 04/06/2021 3:59:52 PM |
Best of luck to you | WolfKlaw | investorshub | 04/05/2021 12:21:15 PM |
I'm going to get some tomorrow finally | Clemdane | investorshub | 04/05/2021 12:21:24 AM |
I have added more on the weakness | WolfKlaw | investorshub | 04/04/2021 5:13:14 PM |
No, didn't have the funds till now actually. | Clemdane | investorshub | 04/04/2021 1:30:30 PM |
Did you ever get in? | WolfKlaw | investorshub | 04/04/2021 12:51:23 PM |
Hope to join you soon | Clemdane | investorshub | 02/14/2021 8:01:52 PM |
I added more this week | WolfKlaw | investorshub | 02/14/2021 1:55:19 PM |
Thanks for answering! This is looking really good. | Clemdane | investorshub | 02/13/2021 2:53:59 AM |
Closing of offering announced. http://www.globenewswire.com/news-release/2021 | EquityMonster83 | investorshub | 02/13/2021 2:20:26 AM |
Nice Ark added 23k ENLV. 411k shares now | EquityMonster83 | investorshub | 02/13/2021 1:39:17 AM |
Sepsis would be a $30b total addressable market, | EquityMonster83 | investorshub | 02/13/2021 1:35:30 AM |
No dont think so. | EquityMonster83 | investorshub | 02/13/2021 1:32:57 AM |
So I'm not too late? | Clemdane | investorshub | 02/12/2021 5:20:41 AM |
$ENLV Covid-19 Treatment. It works. $ENLV Covid-19 Treatment ?? | EquityMonster83 | investorshub | 02/12/2021 1:46:38 AM |
Great | WolfKlaw | investorshub | 02/11/2021 12:20:26 PM |
Nice. In big today around $20 | EquityMonster83 | investorshub | 02/11/2021 12:41:14 AM |
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NYSE Market:
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily ...
Nes-Ziona, Israel, April 29, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company” or “Enlivex”), a clinical-stage macrophage reprogramming immunotherapy company, today issued the following update to shareholders from Chief Executive Officer, ...
Nes-Ziona, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the first two patients have been dosed in the Company’s multi-country, random...